首页|基于二尖瓣反流相关研究探讨经导管二尖瓣置换术适应证

基于二尖瓣反流相关研究探讨经导管二尖瓣置换术适应证

扫码查看
二尖瓣反流(mitral regurgitation,MR)是最常见的瓣膜性心脏病.二尖瓣修复/置换术可改善严重MR患者的预后,但由于合并症和手术风险,很大一部分患者无法耐受外科手术.经导管二尖瓣置换术(transcatheter mitral valve replacement,TMVR)是将人.工瓣膜借助导管送至体内二尖瓣环处并释放固定的治疗手段,具有不开胸、创伤小、安全性高等优势,可用于二尖瓣疾病的治疗.TMVR早期的临床研究显示出良好的结果,但仍面临诸多挑战,严格把握适应证是减少手术风险及术后并发症的有效措施.该文通过分析多项国内外研究,探讨TMVR的相关适应证.
Indications for transcatheter mitral valve replacement based on mitral regurgitation-related research
Mitral regurgitation(MR)is the most common type of valvular heart disease.Mitral valve repair/replacement can improve the prognosis of patients with severe MR,but a large proportion of patients cannot tolerate surgical procedures due to comorbidities and surgical risks.Transcatheter mitral valve replacement(TMVR)is a kind of treatment for mitral valve disease in which an artificial valve is delivered to the mitral valve annulus through a catheter and released into place,with the advantages of no thorax opening,less trauma and high safety.Early clinical studies of TMVR have shown good results,but still face many challenges.Strict indications are effective measures to reduce surgical risks and postoperative complications.This article explores the relevant indications of TMVR by analyzing several studies at home and abroad.

Mitral regurgitationtranscatheter mitral valve replacementindications

吴婵、李妍

展开 >

空军军医大学唐都医院心内科(西安 710032)

二尖瓣反流 经导管二尖瓣置换术 适应证

2024

华西医学
四川大学华西医院

华西医学

CSTPCD
影响因子:0.744
ISSN:1002-0179
年,卷(期):2024.39(9)